A Phase I clinical trial of mosquito-borne disease vaccine AGS-v to evaluate safety in healthy volunteers.

Trial Profile

A Phase I clinical trial of mosquito-borne disease vaccine AGS-v to evaluate safety in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Feb 2017

At a glance

  • Drugs AGS v (Primary)
  • Indications Viral infections
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Feb 2017 New trial record
    • 21 Feb 2017 According to a Halloran Consulting Groups media release, enrollment is expected to complete by August 2017 and the study to complete around June 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top